Prognostic significance of minimal residual disease (MRD) in children with high risk acute lymphoblastic leukemia(ALL). A children's oncology group study.

被引：1
|
作者：
Borowitz, MJ
Devidas, M
Bowman, WP
Larsen, E
Pullen, J
Camitta, B
机构：
[1] Johns Hopkins Med Inst, Baltimore, MD USA
[2] Childrens Oncol Grp, Ctr Data, Gainesville, FL USA
[3] Cook Childrens Hosp, Ft Worth, TX USA
[4] Maine Childrens Canc Program, Scarborough, ME USA
[5] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA
[6] Midw Childrens Canc Ctr, Milwaukee, WI USA
[7] Childrens Oncol Grp, Arcadia, CA USA
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
10.1182/blood.V106.11.85.85
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
85
引用
收藏
页码：29A / 29A
页数：1
相关论文
共 50 条
  • [31] Minimal residual disease detection in childhood precursor-B-cell acute lymphoblastic leukemia: relation to other risk factors. A Children's Oncology Group study
    Borowitz, MJ
    Pullen, DJ
    Shuster, JJ
    Viswanatha, D
    Montgomery, K
    Willman, CL
    Camitta, B
    LEUKEMIA, 2003, 17 (08) : 1566 - 1572
  • [32] Minimal residual disease detection in childhood precursor–B-cell acute lymphoblastic leukemia: relation to other risk factors. A Children's Oncology Group study
    M J Borowitz
    D J Pullen
    J J Shuster
    D Viswanatha
    K Montgomery
    C L Willman
    B Camitta
    Leukemia, 2003, 17 : 1566 - 1572
  • [33] The prognostic significance of minimal residual disease in adult standard risk patients with acute lymphoblastic leukemia.
    Brüggemann, M
    Droese, J
    Raff, T
    Ritgen, M
    Scheuring, U
    Goekbuget, N
    Hoelzer, DF
    Kneba, M
    BLOOD, 2001, 98 (11) : 314A - 314A
  • [34] MONITORING OF MINIMAL RESIDUAL DISEASE IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
    LINDERKAMP, C
    BEYERMANN, B
    BAUMGARTEN, E
    HANEL, C
    SEEGER, K
    SCHMID, H
    ZINGSEM, J
    HENZE, G
    BLOOD, 1993, 82 (10) : A543 - A543
  • [35] Monitoring minimal residual disease in children with high-risk relapses of acute lymphoblastic leukemia: prognostic relevance of early and late assessment
    C Eckert
    N Hagedorn
    L Sramkova
    G Mann
    R Panzer-Grümayer
    C Peters
    J-P Bourquin
    T Klingebiel
    A Borkhardt
    G Cario
    J Alten
    G Escherich
    K Astrahantseff
    K Seeger
    G Henze
    A von Stackelberg
    Leukemia, 2015, 29 : 1648 - 1655
  • [36] Monitoring minimal residual disease in children with high-risk relapses of acute lymphoblastic leukemia: prognostic relevance of early and late assessment
    Eckert, C.
    Hagedorn, N.
    Sramkova, L.
    Mann, G.
    Panzer-Gruemayer, R.
    Peters, C.
    Bourquin, J-P
    Klingebiel, T.
    Borkhardt, A.
    Cario, G.
    Alten, J.
    Escherich, G.
    Astrahantseff, K.
    Seeger, K.
    Henze, G.
    von Stackelberg, A.
    LEUKEMIA, 2015, 29 (08) : 1648 - 1655
  • [37] Prognostic impact of minimal residual disease at the end of consolidation in NCI standard-risk B-lymphoblastic leukemia: A report from the Children's Oncology Group
    Rau, Rachel E.
    Dai, Yunfeng
    Devidas, Meenakshi
    Rabin, Karen R.
    Zweidler-McKay, Patrick
    Angiolillo, Anne
    Schore, Reuven J.
    Burke, Michael J.
    Salzer, Wanda L.
    Heerema, Nyla A.
    Carroll, Andrew J.
    Winick, Naomi J.
    Hunger, Stephen P.
    Raetz, Elizabeth A.
    Loh, Mignon L.
    Wood, Brent L.
    Borowitz, Michael J.
    PEDIATRIC BLOOD & CANCER, 2021, 68 (04)
  • [38] Prognostic impact of minimal residual disease (MRD) in children is different in B or T lineage acute lymphoblastic leukemia:: Results of trial AIEOP-BFM ALL 2000
    Schrappe, Martin
    Rizzari, Carmelo
    Mann, Georg
    Möricke, Anja
    Valsecchi, Maria Grazia
    Zimmermann, Martin
    Bartram, Claus R.
    Panzer-Grijmayer, Renate
    Schrauder, Andr
    Cazzaniga, Gianni
    Flohr, Thomas
    Parasóle, Rosanna
    Reiter, Alfred
    Ludwig, Wolf-Dieter
    Lo Nigro, Luca
    Basso, Giuseppe
    De Rossi, Giulio
    Barisone, Elena
    Niggli, Felix
    Gadner, Helmut
    Conter, Valentino
    BLOOD, 2007, 110 (11) : 427A - 427A
  • [39] COMPARISON OF HIGH-THROUGHPUT SEQUENCING AND FLOW CYTOMETRY FOR MEASURING MINIMAL RESIDUAL DISEASE IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA: A CHILDREN'S ONCOLOGY GROUP COHORT
    Gawad, Charles
    Borowitz, Michael
    Dahl, Gary
    Devidas, Meenakshi
    Faham, Malek
    Moorhead, Martin
    Wood, Brent
    Zheng, Jianbiao
    Loh, Mignon
    Lacayo, Norman
    ANNALS OF HEMATOLOGY, 2013, 92 : S23 - S24
  • [40] Comparison of High-Throughput Sequencing and Flow Cytometry for Measuring Minimal Residual Disease in Pediatric Acute Lymphoblastic Leukemia: A Children's Oncology Group Cohort
    Gawad, Charles
    Borowitz, Michael J.
    Dahl, Gary V.
    Devidas, Meenakshi
    Faham, Malek
    Moorhead, Martin
    Wood, Brent L.
    Zheng, Jianbiao
    Loh, Mignon L.
    Lacayo, Norman J.
    BLOOD, 2012, 120 (21)
12345